Financial Gravity Companies’s AbbVie ABBV Stock Holding History

Financial Gravity Companies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$36.4K	Buy	+196	New	+$36.4K	0.01%	345
2024 Q4	$8.35K	Hold	47	–	–	﹤0.01%	602
2024 Q3	$9.28K	Buy	+47	New	+$8.77K	﹤0.01%	365
2018 Q4	$396K	Buy	+4,921	New	+$433K	0.36%	40
2018 Q1	$396K	Buy	3,949 +1,323	+50%	+$145K	0.41%	41
2017 Q4	$295K	Buy	+2,626	New	+$247K	0.34%	50

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Financial Gravity Companies's ABBV Position: Q2 2025 in Review

Financial Gravity Companies opened a new position in AbbVie (ABBV) in Q2 2025: 196 shares worth $36.4K. The stake represents 0.01% of the portfolio and ranks #345 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in ABBV as recently as Q4 2024.

Financial Gravity Companies first reported a position in ABBV in Q4 2017 and has held it in 6 quarters since. The position peaked at $396K in Q4 2018. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Financial Gravity Companies held 196 shares of AbbVie worth $36.4K as of Q2 2025.
AbbVie was a new Financial Gravity Companies position in Q2 2025.
AbbVie made up 0.01% of Financial Gravity Companies's portfolio in Q2 2025, its #345 holding.
Financial Gravity Companies first reported a position in AbbVie in Q4 2017 and has held it in 6 quarters since.
Financial Gravity Companies's AbbVie position peaked at $396K in Q4 2018.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Financial Gravity Companies's 13F filing for Q2 2025, filed 8 Aug 2025.